← Leaderboards
Jonathan Paul Dyke
Rutgers Biomedical And Health Sciences
$2,268,813
Attributed
$4,537,626
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$4,537,626 · 3
By mechanism
RF1$3,210,645 · 1
R01$1,326,981 · 2
Top collaborators
- Hyung Jin Ahn2 shared
- Arzu Kovanlikaya2 shared
- Douglas J Ballon1 shared
Most similar at Rutgers Biomedical And Health Sciences
Same institution · by research overlap
- Luciano D'adamio$26,657,918
- Anna Borisova Konova$6,433,083
- Emmanuel Eduardo Alvarez$88,636
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposMagnetic Resonance ImagingImpairmentSeveritiesInflammationStrokeAnatomyPerformanceNeonatalImaging TechniquesNervous System DisorderResolutionGadoliniumStructureContrast MediaDiffusion Magnetic Resonance ImagingAffectFunctional Magnetic Resonance ImagingImageNeurodegenerative DisordersLesionAlveolarAreaAchievement
Grant awards (5)
Vascular contribution to white matter lesions and motor dysfunction in AD and ADRD$1,226,883
RF1 · FY2025 · AG
Physiologic phenotyping of chronic lung disease of prematurity using MRI$418,419
R01 · FY2025 · HL
Unified Shim-RF Coil Technology for Improved Whole-Brain Spectroscopic MRI for Neurological Disorders$459,550
R01 · FY2024 · NS
Physiologic phenotyping of chronic lung disease of prematurity using MRI$449,012
R01 · FY2024 · HL
Vascular contribution to white matter lesions and motor dysfunction in AD and ADRD$1,983,762
RF1 · FY2022 · AG